Benadryl neonatal withdrawal risk?

Benadryl neonatal withdrawal risk?

• A. Neonatal withdrawal
• B. Neonatal jaundice
• C. No risk
• D. Neonatal tachycardia

Answer: (A)

Benadryl (diphenhydramine) can cross the placenta, and chronic exposure during pregnancy can lead to a neonatal withdrawal picture after birth as the newborn adapts outside the womb. This withdrawal risk isn’t about a single symptom but a rebound of autonomic and central nervous system effects in the newborn, which can include irritability, high-pitched crying, tremors, poor sleep, and feeding difficulties; sometimes tachycardia or fever can accompany these withdrawal manifestations. Neonatal jaundice, while common in newborns due to immature bilirubin clearance, is not specifically a withdrawal consequence of Benadryl exposure. Saying there is no risk ignores the potential for withdrawal symptoms with in utero exposure. Neonatal tachycardia can occur in withdrawal but by itself doesn’t denote withdrawal risk as a whole; the broader pattern is withdrawal symptoms.

Benadryl (diphenhydramine) can cross the placenta, and chronic exposure during pregnancy can lead to a neonatal withdrawal picture after birth as the newborn adapts outside the womb. This withdrawal risk isn’t about a single symptom but a rebound of autonomic and central nervous system effects in the newborn, which can include irritability, high-pitched crying, tremors, poor sleep, and feeding difficulties; sometimes tachycardia or fever can accompany these withdrawal manifestations.

Neonatal jaundice, while common in newborns due to immature bilirubin clearance, is not specifically a withdrawal consequence of Benadryl exposure. Saying there is no risk ignores the potential for withdrawal symptoms with in utero exposure. Neonatal tachycardia can occur in withdrawal but by itself doesn’t denote withdrawal risk as a whole; the broader pattern is withdrawal symptoms.